Sugi Predict

Sugi Predict / Compounds / SCHEMBL14215976

SCHEMBL14215976

SCHEMBL14215976

CC1=C2C(=O)C=C(CO)[C@@H]2[C@H]2OC(=O)[C@@H](C)[C@@H]2CC1

nearest known ligand 0.71

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.71
▸ ALDH1A1 P00352 2/20 0.71
▸ MEN1 O00255 1/20 0.71
▸ KMT2A Q03164 1/20 0.71
▸ MAPK1 P28482 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ CYP19A1 P11511 2/20 0.39
▸ TAS2R46 P59540 8/20 0.37
▸ TAS2R31 P59538 2/20 0.37
▸ TAS2R10 Q9NYW0 2/20 0.37
▸ RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14533824 0.86 CYP1A2 (0.52) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Desacetoxymatricarin SCHEMBL14190533 0.83 CYP1A2 (1.00) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Desacetoxymatricarin SCHEMBL14029298 0.83 CYP1A2 (1.00) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Desacetoxymatricarin SCHEMBL3458919 0.83 CYP1A2 (1.00) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Desacetoxymatricarin SCHEMBL5004433 0.83 CYP1A2 (1.00) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Desacetoxymatricarin SCHEMBL29420462 0.83 CYP1A2 (1.00) CYP1A2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL14215974 0.77 CYP1A2 (0.72) CYP1A2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL8898751 0.77 CYP1A2 (0.72) CYP1A2ALDH1A1MEN1KMT2AMAPK1
Deoxylactucin SCHEMBL14215979 0.75 CYP19A1 (0.72) CYP1A2ALDH1A1MEN1KMT2AMAPK1
SCHEMBL14533823 0.68 CYP1A2 (0.54) CYP1A2ALDH1A1MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637399-A1 AEROSOL-GENERATING ARTICLE WITH AN AVERSIVE FLAVOURANT IN A REMOVABLE WRAPPER Philip Morris Products S.A. (CH) 2025-10-29 — — EP disclosed
WO-2024133153-A1 AEROSOL-GENERATING ARTICLE WITH AN AVERSIVE FLAVOURANT IN A REMOVABLE WRAPPER PHILIP MORRIS PRODUCTS S.A. (CH) 2024-06-27 — — WO disclosed
WO-2023170340-A1 METHOD OF PRODUCING ANTIMICROBIAL EXTRACT FROM CHICORY TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) 2023-09-14 — — WO disclosed
US-20080124772-A1 Plant enzymes for bioconversion PLANT RESEARCH INTERNATIONAL B.V. 2008-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080124772-A1 Plant enzymes for bioconversion STS, SQLE, CYP51A1 CYP1A2 19/4885ALDH1A1 479/4885MEN1 2349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.